| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.96B | -76.0% |
| Cost of Revenue | $367.0M | -94.3% |
| Gross Profit | $1.59B | -9.3% |
| R&D Expense | $498.0M | +5.0% |
| SG&A Expense | $498.0M | +11.0% |
| Operating Income | -$93.0M | +71.6% |
| Interest Expense | $35.0M | -81.8% |
| Pre-tax Income | -$85.0M | +83.9% |
| Income Tax | $3.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.47B | -43.9% |
| Accounts Receivable | $72.0M | -53.5% |
| Current Assets | $3.60B | -53.1% |
| Total Assets | $6.56B | -38.6% |
| Current Liabilities | $270.0M | -93.0% |
| Total Liabilities | $2.08B | -61.1% |
| Stockholders' Equity | $4.48B | -16.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.50B | +241.8% |
| Capital Expenditures | $115.0M | +56.9% |
| Investing Cash Flow | -$1.53B | -240.9% |
| Financing Cash Flow | -$4.34B | -237.9% |
| Free Cash Flow | $4.39B | +235.0% |
| +137.5% |
| Net Income | -$101.0M | +80.9% |
| EPS (Basic) | -$0.42 | +80.1% |
| EPS (Diluted) | -$0.42 | +80.1% |